Newborn Screening Market Size, Share & Trends Analysis Report By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Test Type, By Product (Instruments, Reagents), By Region, And Segment Forecasts, 2023 - 2030

Research Methodology

A three-pronged approach was followed for deducing the newborn screening market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for newborn screening market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of newborn screening market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Newborn Screening Market Categorization:

The newborn screening market was categorized into four segments, namely product (Instruments, Reagents), technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assay, DNA Assayt, Electrophoresis), test type (Dry Blood Spot Test, CCHD, Hearing Screen), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The newborn screening market was segmented into product, technology, test type, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The newborn screening market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Newborn screening market companies & financials:

The newborn screening market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• Covidien plc - Dublin-based Covidien plc is a medical device firm that was founded in 2007. Covidien offers surgical goods, vascular therapy, and respiratory and monitoring tools to help individuals all over the world with their healthcare needs. Covidien employed more than 39,000 people in 2014 and operated in more than 150 nations. To combine synergies, build a larger organization, and hasten the introduction of new products and services, Medtronic finalized the acquisition of Covidien in January 2015.

• AB Sciex LLC - AB Sciex LLC is a US-based company that was established in 1986. It operates in China, Australia, Europe, Canada, Singapore, and California. After being purchased by Danaher Corp. in 2010, AB Sciex LLC is now a subsidiary of that company. AB Sciex develops and offers scientific instruments, software, and services for the life sciences, industrial markets, and clinical research both domestically and abroad. Environmental testing, food and beverage testing, genomics research, biomarker discovery, genetic analysis, biologics, capillary electrophoresis, clinical diagnostics, clinical research, drug discovery and development, and forensic toxicology are among the fields in which mass spectrometry is applied.

• Bio Rad Laboratories - David Schwartz established Bio-Rad Laboratories in the United States in the year 1952. It employed over 7,500 people as of 2014. With a product portfolio of more than 8,000, it works in the life science, research, and clinical diagnostics fields. The Life Science Group is engaged in the development and production of a wide variety of equipment, consumables, and lab instruments. The creation and marketing of medical screening and diagnostics is the responsibility of the Clinical Diagnostics Group.

• Agilent Technologies - The U.S.-based technology corporation Agilent Technologies specializes in pharmaceuticals, environmental, food, forensics, applied chemical markets, life sciences, and diagnostics. Following its separation from Hewlett-Packard Company, Agilent was founded in 1999. In addition to producing equipment, the firm offers services, applications, consumables, and expertise to labs worldwide.

• Masimo Corporation - Joe Kiani established Masimo Corporation in 1989. The firm employs about 2,500 individuals globally, with its corporate headquarters located in the United States. Masimo Corporation is a company that develops, produces, and markets medical devices, a variety of sensors, and noninvasive patient monitoring technology. With manufacturers of patient monitoring equipment worldwide, including Spacelabs, Atom, Zoll, Datascope, Philips, GE Medical, and Medtronic, the corporation has technology licensing and OEM agreements.

• Waters Corporation - American-based Waters Corporation was founded in 1958. Thermal analysis, liquid chromatography, and mass spectrometry are Waters' primary areas of expertise when it comes to the design, manufacture, sales, and servicing of analytical technologies. The two divisions that make up Waters Corp. are TA Instruments and Waters Division. Technologies for mass spectrometry and liquid chromatography are included in the Waters Division. Thermal analysis technologies are the focus of TA Instruments.

• Natus Medical - The U.S. headquarters of Natus Medical were established in 1989. The development and production of medical equipment and software for neurology, sleep, hearing, and infant care therapies are the company's main capabilities. Products from Natus are sold and supported in more than 100 countries. The business produces newborn and neonatal care items for the diagnosis and treatment of jaundice and brain damage. Additionally, these systems aid in the diagnosis of neurological diseases including epilepsy, balance issues, and sleep difficulties.

• Trivitron Healthcare - Founded in 1997, Trivitron Healthcare is an Indian healthcare technology firm. Its primary expertise are in imaging, critical & cardiac care, ophthalmology, and laboratory medicine research and manufacturing. It operates throughout the Middle East, South East Asia, Africa, Europe, India, and the United Arab Emirates. Trivitron and Aloka (Japan) have a joint venture (JV). In addition, Trivitron has joint ventures (JVs) with Johnson Medical in Sweden and Biosystems in Spain for the development and production of various medical technology products.

• Perkin Elmer - A leader in detection, informatics, imaging, and service capabilities for environmental and human health, Perkin Elmer is a medical technology company. It works in more than 150 countries and employs 7,700 people. The corporation presently has over 3,000 patents and its headquarters are in the United States.

• GE LifeSciences - GE LifeSciences is a global company with interests in industrial engineering, healthcare, and energy. GE has operations in 175 nations. GE Healthcare includes GE LifeSciences as a division. Molecular precision medicine and analytical technologies are the life sciences vertical's fundamental competences, and they will enhance patient outcomes. The pharmaceutical and biopharmaceutical industries are served by life sciences. GE Healthcare received a contribution of almost USD 4 billion from GE LifeSciences in 2014.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Newborn Screening Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Newborn Screening Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.